159 related articles for article (PubMed ID: 25080093)
1. Choice of non-inferiority (NI) margins does not protect against degradation of treatment effects on an average--an observational study of registered and published NI trials.
Gladstone BP; Vach W
PLoS One; 2014; 9(7):e103616. PubMed ID: 25080093
[TBL] [Abstract][Full Text] [Related]
2. About half of the noninferiority trials tested superior treatments: a trial-register based study.
Gladstone BP; Vach W
J Clin Epidemiol; 2013 Apr; 66(4):386-96. PubMed ID: 23337782
[TBL] [Abstract][Full Text] [Related]
3. Noninferiority hypotheses and choice of noninferiority margin.
Ng TH
Stat Med; 2008 Nov; 27(26):5392-406. PubMed ID: 18680173
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Current issues in non-inferiority trials.
Fleming TR
Stat Med; 2008 Feb; 27(3):317-32. PubMed ID: 17340597
[TBL] [Abstract][Full Text] [Related]
6. When inferiority meets non-inferiority: implications for interim analyses.
Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
[TBL] [Abstract][Full Text] [Related]
7. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
8. The use of randomisation-based efficacy estimators in non-inferiority trials.
Gillespie D; Farewell D; Barrett-Lee P; Casbard A; Hawthorne AB; Hurt C; Murray N; Probert C; Stenson R; Hood K
Trials; 2017 Mar; 18(1):117. PubMed ID: 28274254
[TBL] [Abstract][Full Text] [Related]
9. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
Weir IR; Trinquart L
Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
[TBL] [Abstract][Full Text] [Related]
10. Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials.
Donken R; de Melker HE; Rots NY; Berbers G; Knol MJ
Vaccine; 2015 Mar; 33(12):1426-32. PubMed ID: 25659273
[TBL] [Abstract][Full Text] [Related]
11. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
[TBL] [Abstract][Full Text] [Related]
12. An evidential approach to non-inferiority clinical trials.
Wang SJ; Blume JD
Pharm Stat; 2011; 10(5):440-7. PubMed ID: 21928286
[TBL] [Abstract][Full Text] [Related]
13. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
Ganju J; Rom D
Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
[TBL] [Abstract][Full Text] [Related]
14. Non-inferiority trials in breast and non-small cell lung cancer: choice of non-inferiority margins and other statistical aspects.
Saad ED; Buyse M
Acta Oncol; 2012 Sep; 51(7):890-6. PubMed ID: 22974094
[TBL] [Abstract][Full Text] [Related]
15. Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpoint.
Ni S; Yu Q; Zhong Z; Yang M; Zhao Y; Wu J; Bai J; Yu H
J Biopharm Stat; 2023 Jan; 33(1):15-30. PubMed ID: 35791856
[TBL] [Abstract][Full Text] [Related]
16. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
Li Z; Quartagno M; Böhringer S; van Geloven N
Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
[TBL] [Abstract][Full Text] [Related]
17. ['Non-inferiority' trials. Tips for the critical reader. Research methodology 3].
Soonawala D; Dekkers OM
Ned Tijdschr Geneeskd; 2012; 156(19):A4665. PubMed ID: 22571548
[TBL] [Abstract][Full Text] [Related]
18. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
19. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
Siqueira AL; Whitehead A; Todd S
Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
[TBL] [Abstract][Full Text] [Related]
20. How do we know a treatment is good enough? A survey of non-inferiority trials.
Attard N; Totton N; Gillies K; Goulao B
Trials; 2022 Dec; 23(1):1021. PubMed ID: 36527129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
